Did more people die who received a vaccine or a placebo in the primary clinical trial used by the FDA to approve Pfizer's Covid-19 vaccine?
Buried 23 pages into its approval summary for Pfizer's C-19 vaccine, the FDA reveals "there were a total of 38 deaths" during its primary clinical trial, including 21 people who received the vaccine and "17 in the placebo group." This was a randomized controlled trial (RCT), which is the "gold standard" for clinical research because it provides "a rigorous tool to examine cause-effect." Considered together with the fact that about half of the 40,000 people in the trial received a placebo, these results show no statistically significant impact on the risk of death. This finding is subject to limitations that could have been lessened if Pfizer and other vaccine manufacturers had not ejected participants from their RCTs after a maximum of six months. Yet, the manufacturers did that in defiance of government healthcare regulatory agencies who recommended that the subjects be enrolled for at least one year.